Literature DB >> 26137395

CD4+ T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells-novel implications of CD4+ T cells in pancreatic cancer development.

Lisa Goebel1, Evelin Grage-Griebenow1, Artur Gorys1, Ole Helm1, Geeske Genrich1, Lennart Lenk1, Daniela Wesch2, Hendrik Ungefroren3, Sandra Freitag-Wolf4, Bence Sipos5, Christoph Röcken6, Heiner Schäfer7, Susanne Sebens1.   

Abstract

Chronic pancreatitis (CP) is a risk factor of pancreatic ductal adenocarcinoma (PDAC) and characterized by a pronounced desmoplastic reaction with CD4+ T cells accounting for the majority of the stromal T cell infiltrate. Epithelial-mesenchymal-transition (EMT) is a critical process for metastasis by which epithelial/carcinoma cells become enabled to disseminate probably prior to tumor formation. To investigate whether CD4+ T cells induce EMT in human pancreatic ductal epithelial cells, premalignant H6c7 cells were mono- or co-cultured with human CD4+CD25+CD127-CD49d- regulatory T cells (T-regs) or CD4+CD25- T-effector cells (T-effs) being isolated by negative magnetic bead separation from blood of healthy donors. Particularly in the presence of activated T-effs, H6c7 cells acquired a spindle-shaped morphology, reduced E-cadherin expression, and elevated expression of the mesenchymal proteins vimentin, L1CAM, and ZEB-1. This was accompanied by an increased invasive behavior. Moreover, activated T-effs exerted similar effects in the PDAC cell line T3M4. Blocking of TNF-α and IL-6 being released at greater amounts into supernatants during co-cultures with activated T-effs attenuated the EMT-associated alterations in H6c7 cells. Supporting these findings, EMT-associated alterations (exemplified by reduced E-cadherin expression and enhanced expression of vimentin and L1CAM) were predominantly detected in ductal epithelium of CP tissues surrounded by a dense stroma enriched with CD4+ T cells. Overall this study points to a novel role of CD4+ T cells beyond their immune function in pancreatic tumorigenesis and underscores the view that EMT induction in pancreatic ductal epithelial cells represents an early event in PDAC development being essentially promoted by inflammatory processes.

Entities:  

Keywords:  AUC, area under the curve; CP, chronic pancreatitis; E-cadherin; EMT, epithelial-mesenchymal-transition; L1CAM; PBMC, peripheral blood mononuclear cells; PDAC, pancreatic ductal adenocarcinoma; PanIN, pancreatic intraepithelial neoplasia; SD, standard deviation; T-effs, CD4+CD25− T-effector cells; T-regs, CD4+CD25+CD127−CD49d− regulatory T cells; cell invasion; chronic pancreatitis; pancreatic cancer precursor lesion; tumor stroma

Year:  2015        PMID: 26137395      PMCID: PMC4485733          DOI: 10.1080/2162402X.2014.1000083

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  38 in total

1.  Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients.

Authors:  Tetsuya Ikemoto; Takeshi Yamaguchi; Yuji Morine; Satoru Imura; Yuji Soejima; Masahiko Fujii; Yoichi Maekawa; Koji Yasutomo; Mitsuo Shimada
Journal:  Pancreas       Date:  2006-11       Impact factor: 3.327

2.  Location, location, location: macrophage positioning within tumors determines pro- or antitumor activity.

Authors:  Lee B Rivera; Gabriele Bergers
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

3.  Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression.

Authors:  Anchalee Techasen; Nisana Namwat; Watcharin Loilome; Kassaporn Duangkumpha; Anucha Puapairoj; Hideyuki Saya; Puangrat Yongvanit
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-05-27       Impact factor: 7.027

4.  Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

Authors:  Nobuyoshi Hiraoka; Kaoru Onozato; Tomoo Kosuge; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

5.  Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.

Authors:  S Sebens Müerköster; V Werbing; B Sipos; M A Debus; M Witt; M Grossmann; D Leisner; J Kötteritzsch; H Kappes; G Klöppel; P Altevogt; U R Fölsch; H Schäfer
Journal:  Oncogene       Date:  2006-11-06       Impact factor: 9.867

6.  M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer.

Authors:  Hiroshi Kurahara; Sonshin Takao; Kosei Maemura; Yuko Mataki; Taisaku Kuwahata; Koki Maeda; Masahiko Sakoda; Satoshi Iino; Sumiya Ishigami; Shinichi Ueno; Hiroyuki Shinchi; Shoji Natsugoe
Journal:  Pancreas       Date:  2013-01       Impact factor: 3.327

7.  L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression.

Authors:  Evelin Grage-Griebenow; Elfi Jerg; Artur Gorys; Daniel Wicklein; Daniela Wesch; Sandra Freitag-Wolf; Lisa Goebel; Ilka Vogel; Thomas Becker; Michael Ebsen; Christoph Röcken; Peter Altevogt; Udo Schumacher; Heiner Schäfer; Susanne Sebens
Journal:  Mol Oncol       Date:  2014-04-02       Impact factor: 6.603

8.  Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.

Authors:  Claudia Geismann; Mascha Morscheck; Dorothee Koch; Frank Bergmann; Hendrik Ungefroren; Alexander Arlt; Ming-Sound Tsao; Max G Bachem; Peter Altevogt; Bence Sipos; Ulrich R Fölsch; Heiner Schäfer; Susanne Sebens Müerköster
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

Review 9.  Pancreatic cancer microenvironment.

Authors:  Jörg Kleeff; Philipp Beckhove; Irene Esposito; Stephan Herzig; Peter E Huber; J Matthias Löhr; Helmut Friess
Journal:  Int J Cancer       Date:  2007-08-15       Impact factor: 7.396

10.  Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.

Authors:  N Liu; T Furukawa; M Kobari; M S Tsao
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

View more
  15 in total

Review 1.  Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.

Authors:  Charli Dominguez; Justin M David; Claudia Palena
Journal:  Semin Cancer Biol       Date:  2017-08-18       Impact factor: 15.707

Review 2.  Metastasis prevention: targeting causes and roots.

Authors:  A A Schegoleva; A A Khozyainova; T S Gerashchenko; L D Zhuikova; Evgeny V Denisov
Journal:  Clin Exp Metastasis       Date:  2022-03-26       Impact factor: 4.510

3.  Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.

Authors:  Xuequan Wang; Ziming Xing; Huihui Xu; Haihua Yang; Tongjing Xing
Journal:  Aging (Albany NY)       Date:  2021-04-30       Impact factor: 5.682

Review 4.  The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System.

Authors:  Elisabetta Romeo; Carmelo Antonio Caserta; Cristiano Rumio; Fabrizio Marcucci
Journal:  Cells       Date:  2019-05-15       Impact factor: 6.600

Review 5.  The Immune Microenvironment and Cancer Metastasis.

Authors:  Asmaa El-Kenawi; Kay Hänggi; Brian Ruffell
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

Review 6.  New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

7.  The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.

Authors:  Sarah Arfmann-Knübel; Birte Struck; Geeske Genrich; Ole Helm; Bence Sipos; Susanne Sebens; Heiner Schäfer
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

8.  Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment induced by Reg3g overexpression.

Authors:  Xiulan Liu; Zhongshi Zhou; Qi Cheng; Hongjie Wang; Hui Cao; Qianqian Xu; Yali Tuo; Li Jiang; You Zou; Hongyu Ren; Ming Xiang
Journal:  Cell Death Dis       Date:  2017-09-07       Impact factor: 8.469

Review 9.  An Immunological Glance on Pancreatic Ductal Adenocarcinoma.

Authors:  Michael Karl Melzer; Frank Arnold; Katja Stifter; Friedemann Zengerling; Ninel Azoitei; Thomas Seufferlein; Christian Bolenz; Alexander Kleger
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

Review 10.  Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis.

Authors:  Jacek Baj; Karolina Brzozowska; Alicja Forma; Amr Maani; Elżbieta Sitarz; Piero Portincasa
Journal:  Int J Mol Sci       Date:  2020-04-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.